Feasibility of the Menstrual Cup for VVF

NCT ID: NCT03414060

Last Updated: 2018-10-19

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 35 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2016-08-08
• Study Completion Date: 2019-01-25

Brief Summary

This study examines the feasibility and acceptability of the vaginal menstrual cup for short-term management of vesicovaginal fistula (VVF) among 11 women seeking treatment at a health facility in Ghana. The repeated measures design utilizes a 2-hr pad test to compare urinary leakage with and without the insertable cup, a questionnaire on acceptability and perceived effect is administered and a clinical exam is completed. Subsequently, semi-structured interviews will be carried out with up to 24 additional women seeking treatment at a health facility in Ghana. Interviews will cover women's experiences of living with fistula, including strategies for coping with urinary incontinence and resulting stigma, as well as user acceptability to the intervention.

Detailed Description

Vesicovaginal fistula (VVF) is a debilitating maternal morbidity that largely results from complications of prolonged, obstructed labor when the trapped fetal head applies direct pressure to pelvic/vaginal tissues and causes widespread ischemia, tissue necrosis, and subsequent extensive fistula formation. Women living with VVF, the most common anatomical presentation of obstetric fistula, experience urinary incontinence which causes discomfort, malodor, and skin infection, as well as social and psychological consequences that increase their vulnerability to the negative effects of stigma and reduce their quality of life.

Traditional management requires surgical repair; however, many women either do not have access to surgery, or access is delayed due to various individual, social, or structural barriers. Non-surgical management, previously explored with non-invasive techniques for residual urinary incontinence, has been under-examined for fistula-related urinary incontinence. The menstrual cup may be a useful option for non-surgical management of obstetric fistula. Clinical and programmatic reports suggest a potential translation of the menstrual cup for collection or control of urine leakage in women with VVF; however, evidence has not been collected and examined systematically within a population in an endemic setting.

While surgical management of fistula remains the gold standard in treatment, research on non-surgical therapies is necessary.Therefore, this study aims to assess the feasibility (including efficacy, safety, and acceptability among users) of using the menstrual cup over a short period among women seeking care for VVF in a clinical setting and, unlike prior reports, includes standardized measures of leakage and prioritizes user perspectives.

A repeated measures design compared volume of leakage with the and without the cup to baseline leakage via a 2-hr pad test among women with VVF seeking surgical repair at a health facility in Ghana. A questionnaire was later administered followed by a physical exam. A paired t-test was used to analyze effect.

Beginning October 2018, semi-structured interviews with up to 24 women seeking treatment at a health facility in Ghana will be carried out on women's experience with fistula, including strategies for coping with urinary incontinence and resulting stigma, as well as their acceptability to the insertable device. This mixed methods approach is necessary to compare quantitative results and qualitative findings regarding what women are already doing to cope with incontinence and stigma, and their acceptability to this device to manage leaking and support coping.

Conditions

Vaginal Fistula; Vesico Vaginal Fistula; Obstetric; Injury

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Intervention (Menstrual Cup)

The menstrual cup is a 100% silicone, flexible reservoir cup that, when inserted correctly in the vagina, is sanitary and efficacious in preventing leakage of menstrual blood and in eliminating odor.

Group Type: EXPERIMENTAL

Menstrual Cup

Intervention Type: DEVICE

Interventions

Menstrual Cup

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Patient seeking surgical repair for VVF

2. VVF confirmed by gynecologic examination

3. Adequate vaginal capacity to accommodate the menstrual cup

4. Fistula high in vagina (determined at gynecologic examination)

5. Willingness to insert and remove the device by one's self

Exclusion Criteria

1. Technically difficult to insert and or remove the menstrual cup (eg severely scarred vagina)

2. Unable or unwilling to learn to insert and remove the menstrual cup

3. Patient who declines consent or is incapable of consent

4. Presence of rectovaginal fistula (RVF) or combined RVF and VVF

5. Fistula low in the vagina precluding collection of urine by the menstrual cup

• Minimum Eligible Age: 15 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

New York University College of Global Public Health

UNKNOWN

Sponsor Role: collaborator

NYU Langone Health

OTHER

Sponsor Role: collaborator

Korle-Bu Teaching Hospital, Accra, Ghana

OTHER

Sponsor Role: collaborator

University of Ghana Medical School

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Gabriel YK Ganyaglo, MPH, MSCI

Role: PRINCIPAL_INVESTIGATOR

Korle-Bu Teaching Hospital, Accra, Ghana

Locations

Mercy Women's Catholic Hospital

Mankessim, Central Region, Ghana

Site Status: RECRUITING

Countries

Ghana

Central Contacts

Nessa Ryan, MPH, MSCI

Role: CONTACT

ryann01@nyu.edu

Facility Contacts

Nessa Ryan, MPH, MSCI

Role: primary

ryann01@nyu.edu

+1.704.806.2062

Gabriel Ganyaglo, MD

Role: backup

gganyaglo@hotmail.com

+1.704.806.2062

Other Identifiers

CHS-Et/M.9-P3.2/2015-2016

Identifier Type: -

Identifier Source: org_study_id